Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.

Literature DB >> 1349825

Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.

A Gjerris¹, E Widerlöv, L Werdelin, R Ekman.

Abstract

Concentrations of Neuropeptide Y-like (NPY-LI) immunoreactivity in cerebrospinal fluid (CSF) were measured in a group of depressed patients (n = 24) and compared with that of control subjects (n = 12). CSF-NPY-LI was significantly reduced in the group of non-endogenously depressed patients when classified according to Newcastle Rating Scale for Depression--1971 (N-II). No significant correlation was found in the control or depressed groups between lumbar concentrations of NPY-LI and a number of other neurotransmitters.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1992 PMID： 1349825 PMCID： PMC1188381

Source DB: PubMed Journal: J Psychiatry Neurosci ISSN： 1180-4882 Impact factor: 6.186

19 in total

1. The assessment of anxiety states by rating.

Authors: M HAMILTON
Journal: Br J Med Psychol Date: 1959

2. A rating scale for depression.

Authors: M HAMILTON
Journal: J Neurol Neurosurg Psychiatry Date: 1960-02 Impact factor: 10.154

3. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema.

Authors: N J Christensen
Journal: Clin Sci Mol Med Date: 1973-08

4. Neuropeptide Y: complete amino acid sequence of the brain peptide.

Authors: K Tatemoto
Journal: Proc Natl Acad Sci U S A Date: 1982-09 Impact factor: 11.205

5. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

Authors: B J Carroll; M Feinberg; J F Greden; J Tarika; A A Albala; R F Haskett; N M James; Z Kronfol; N Lohr; M Steiner; J P de Vigne; E Young
Journal: Arch Gen Psychiatry Date: 1981-01

6. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat.

Authors: B J Everitt; T Hökfelt; L Terenius; K Tatemoto; V Mutt; M Goldstein
Journal: Neuroscience Date: 1984-02 Impact factor: 3.590

7. The Melancholia Scale and the Newcastle Scales. Item-combinations and inter-observer reliability.

Authors: P Bech; A Gjerris; J Andersen; S Bøjholm; P Kramp; T G Bolwig; M Kastrup; L Clemmesen; O J Rafaelsen
Journal: Br J Psychiatry Date: 1983-07 Impact factor: 9.319

8. Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders.

Authors: A Gjerris; O J Rafaelsen; P Vendsborg; J Fahrenkrug; J F Rehfeld
Journal: J Affect Disord Date: 1984-12 Impact factor: 4.839

9. The Hamilton Anxiety Scale. Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders.

Authors: A Gjerris; P Bech; S Bøjholm; T G Bolwig; P Kramp; L Clemmesen; J Andersen; E Jensen; O J Rafaelsen
Journal: J Affect Disord Date: 1983-05 Impact factor: 4.839

Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls.

1. The assessment of anxiety states by rating.

2. A rating scale for depression.

3. Plasma noradrenaline and adrenaline in patients with thyrotoxicosis and myxoedema.

4. Neuropeptide Y: complete amino acid sequence of the brain peptide.

5. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

6. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat.

7. The Melancholia Scale and the Newcastle Scales. Item-combinations and inter-observer reliability.

8. Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders.

9. The Hamilton Anxiety Scale. Evaluation of homogeneity and inter-observer reliability in patients with depressive disorders.

10. Neuropeptide Y distribution in human brain.

1. Neuropeptide Y Regulates Sleep by Modulating Noradrenergic Signaling.

Review 2. Neuropeptides in depression: role of VGF.

3. Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Review 4. Sex Differences in the Neuropeptide Y System and Implications for Stress Related Disorders.